OBJECTIVES: The purpose of this project was to assess the utility and feasibility of a telephone-based systematic clinical assessment service, the Behavioral Health Laboratory (BHL), in the context of primary care. The BHL is a clinical service that provides primary care providers with an assessment and a summary of mental health and substance abuse (MH/SA) symptoms and provides treatment decision support, including triage to specialty MH/SA services. The BHL was implemented to assist in the evaluation of patients who screened positively for depression at an annual clinical appointment or who were identified through routine care. METHODS: Results from systematic screening of primary care patients were extracted during a period of 6 months prior to implementation of the BHL and after implementation of the BHL. Descriptive results of the 580 evaluations conducted during this time were available. RESULTS: Results suggest an association between the implementation of the BHL and an increase in the proportion of patients screened for depression in primary care. In addition, there was an increase in the proportion of patients who screened positively (2.8% vs 7.0%). The BHL was successful in providing a comprehensive assessment for 78% of those referred. Significant co-occurring mental illness and substance misuse were found among those assessed. CONCLUSIONS: Introducing the BHL into primary care was associated with an apparent change in clinical practice in primary care at the Philadelphia VA Medical Center. Not only were more patients identified, the broad-based approach of the BHL identified significant comorbidity with alcohol misuse, illicit drugs, and suicidal ideation, symptoms likely to have been missed in routine clinical practice. The BHL offers a practical, low-cost method of assessment, monitoring, and treatment planning for patients identified in primary care with MH/SA needs.
OBJECTIVES: The purpose of this project was to assess the utility and feasibility of a telephone-based systematic clinical assessment service, the Behavioral Health Laboratory (BHL), in the context of primary care. The BHL is a clinical service that provides primary care providers with an assessment and a summary of mental health and substance abuse (MH/SA) symptoms and provides treatment decision support, including triage to specialty MH/SA services. The BHL was implemented to assist in the evaluation of patients who screened positively for depression at an annual clinical appointment or who were identified through routine care. METHODS: Results from systematic screening of primary care patients were extracted during a period of 6 months prior to implementation of the BHL and after implementation of the BHL. Descriptive results of the 580 evaluations conducted during this time were available. RESULTS: Results suggest an association between the implementation of the BHL and an increase in the proportion of patients screened for depression in primary care. In addition, there was an increase in the proportion of patients who screened positively (2.8% vs 7.0%). The BHL was successful in providing a comprehensive assessment for 78% of those referred. Significant co-occurring mental illness and substance misuse were found among those assessed. CONCLUSIONS: Introducing the BHL into primary care was associated with an apparent change in clinical practice in primary care at the Philadelphia VA Medical Center. Not only were more patients identified, the broad-based approach of the BHL identified significant comorbidity with alcohol misuse, illicit drugs, and suicidal ideation, symptoms likely to have been missed in routine clinical practice. The BHL offers a practical, low-cost method of assessment, monitoring, and treatment planning for patients identified in primary care with MH/SA needs.
Authors: Sue E Levkoff; Hongtu Chen; Eugenie Coakley; Elizabeth C McDonel Herr; David W Oslin; Ira Katz; Stephen J Bartels; James Maxwell; Edwin Olsen; Keith M Miles; Giuseppe Constantino; James H Ware Journal: J Aging Health Date: 2004-02
Authors: Martha L Bruce; Thomas R Ten Have; Charles F Reynolds; Ira I Katz; Herbert C Schulberg; Benoit H Mulsant; Gregory K Brown; Gail J McAvay; Jane L Pearson; George S Alexopoulos Journal: JAMA Date: 2004-03-03 Impact factor: 56.272
Authors: David W Oslin; Steven Sayers; Jennifer Ross; Vince Kane; Thomas Ten Have; Joseph Conigliaro; Jack Cornelius Journal: Psychosom Med Date: 2003 Nov-Dec Impact factor: 4.312
Authors: Shahrzad Mavandadi; Karen S Rook; Jason T Newsom; David W Oslin Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2012-06-22 Impact factor: 4.328
Authors: Gregory P Beehler; Jennifer S Funderburk; Paul R King; Kyle Possemato; John A Maddoux; Wade R Goldstein; Michael Wade Journal: J Clin Psychol Med Settings Date: 2020-03
Authors: Rasheed A Balogun; Emaad M Abdel-Rahman; Seki A Balogun; Evan H Lott; Jun Ling Lu; Sandra M Malakauskas; Jennie Z Ma; Kamyar Kalantar-Zadeh; Csaba P Kovesdy Journal: Clin J Am Soc Nephrol Date: 2012-08-16 Impact factor: 8.237
Authors: Subhajit Chakravorty; Michael A Grandner; Henry R Kranzler; Shahrzad Mavandadi; Mitchel A Kling; Michael L Perlis; David W Oslin Journal: Am J Addict Date: 2013 May-Jun
Authors: James C Lin; Mitchell P Karno; Lingqi Tang; Kristen L Barry; Frederic C Blow; James W Davis; Karina D Ramirez; Sandra Welgreen; Marc Hoffing; Alison A Moore Journal: J Gen Intern Med Date: 2010-01-26 Impact factor: 5.128